R-ras - OmicsDI

Show results for

Transcriptomics (1459)
Unknown (482)
Genomics (170)
Proteomics (97)
Metabolomics (13)
Models (7)
Other (2)
Clinical (1)

Organisms

Homo sapiens (729)
Mus musculus (343)
Rattus norvegicus (55)
Saccharomyces cerevisiae (48)
Arabidopsis thaliana (36)
Oryza sativa Japonica Group (29)
Oryza sativa (27)
Drosophila melanogaster (24)
Streptococcus pneumoniae D39 (16)
Sus scrofa (15)
Danio rerio (13)
Caenorhabditis elegans (10)
Candida albicans (10)
Gallus gallus (9)
Zea mays (8)
Schizosaccharomyces pombe (8)
Bos taurus (8)
Saccharomyces cerevisiae SK1 (6)
Escherichia coli (6)
Carassius auratus (5)
Macaca mulatta (4)
Medicago truncatula (4)
Salmo salar (4)
Fagus sylvatica (4)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (3)
Scophthalmus maximus (3)
Synechocystis sp. PCC 6803 (3)
Bacillus subtilis subsp. subtilis str. 168 (3)
Brassica napus (3)
Populus euphratica (3)

Organisms

Homo sapiens (25)
Mus musculus (11)
Drosophila melanogaster (5)
Rattus norvegicus (2)
Rhizopus microsporus (1)
Mus (1)
Sus scrofa (1)

Repository

biostudies-arrayexpress (1492)
EGA (62)
ENA (58)
MassIVE (40)
geo (31)
pride (26)
MetaboLights (13)
PAXDB (12)
BioModels (7)
iProX (5)
jPOST (3)
GPMDB (1)
PanoramaPublic (1)

Tissue

Cell culture (13)
Permanent cell line cell (9)
Smooth muscle cell (3)
Fibroblast (2)
Oral epithelium (1)
MEF cell (1)
Pancreatic duct (1)
Pancreatic ductal cell (1)
Embryonic fibroblast (1)
Bone marrow (1)
Lung (1)
Epithelial cell (1)
B cell (1)
Blood cell (1)
Colon (1)
Blood (1)

Disease

Carcinoma (5)
Adenocarcinoma (2)
Normal (2)
Pancreatic ductal adenocarcinoma (2)
Pancreatic cancer (2)
Metastatic colorectal cancer (1)
GIP-dependent Cushing's syndrome (1)
HPV positive (1)
Osteosarcoma subtype fibroblastic (1)
High grade glioblastoma (1)
Cocaine addiction (1)
Perineural invasion (1)
Uninfected (1)
Schizophrenia (1)
Colorectal cancer (1)
Invasive lobular carcinoma (1)
Colorectal carcinoma (1)
Colon adenocarcinoma (1)
Osteosarcoma (1)
Glioblastoma (1)
Colorectal Neoplasms (1)
Not Available (1)
Neurilemmomatosis (1)
Noonan syndrome (1)
Chronic myeloid leukemia (1)
Malignant neoplasm of ovary (1)
Colon cancer (1)
Acute leukemia (1)

Technology Type

Mass Spectrometry (26)
Shotgun proteomics (15)
Mass spectrometry (11)
Bottom-up proteomics (6)
Illumina HiSeq 2500 (3)
Data-independent acquisition (3)
Affinity purification coupled with mass spectrometry proteomics (3)
Illumina HiSeq 2000 (2)
Illumina MiSeq (2)
Top-down proteomics (2)
ILLUMINA, Illumina HiSeq 2500, HiSeq X Ten (1)
Illumina HiSeq 4000, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2000 (1)
NMR spectroscopy (1)
Mass spectrometry assay (1)
Data-dependent acquisition (1)

Instrument Platform

Illumina NovaSeq 6000 (18)
NextSeq 500 (9)
Illumina HiSeq 2000 (8)
Illumina HiSeq 2500 (7)
NextSeq 550 (4)
NextSeq 2000 (3)
Illumina MiSeq (3)
Axon Instruments GenePix 4000B scanner (2)
Illumina HiSeq 3000 (2)
Illumina HiSeq 4000 (2)
Zephyr G3 NGS workstation (1)
MiRNeasy Micro kit (1)
Radial JawTM (1)
MA900, Sony (1)
10x Chromium Controller (1)
10X Chromium Controller (1)
Agilent 2100 Bioanalyzer, Applied Biosystems 7900HT Sequence Detection System, Illumina TruSeq Small RNA Sample Preparation Kit (1)
RNeasy mini Kit, Ribo-Zero Human/Mouse/Rat kit (1)
Illumina iScan (1)
Applied Biosystems 1700 Chemiluminescent Microarray Analyzer (1)
Agilent 2100 Bioanalyzer (1)
GeneChip 3000 7G scanner (Affymetrix) (1)
GentleMACS Dissociator with M tubes (Miltenyi Biotec), QIAzol Lysis Reagent (Qiagen), and RNeasy Microarray Tissue Mini Kit with optional DNase treatment (Qiagen) (1)
Hybridization Cocktails, Mouse Transcriptome 1.0 ST GeneChips, GeneChip Hybridization oven 645 (all Affymetrix) (1)
Bioanalyzer (Agilent), Nanodrop (Thermo Fisher Scientific), and Affymetrix WT Plus Reagent Kit (1)
ScanArray 5000 [PerkinElmer] (1)
GenePix 4000A [Axon Instruments] (1)
Illumina Genome Analyzer IIx (1)
418 [Affymetrix] (1)
ScanArray Express HT [PerkinElmer] (1)

Publication Date

2015 (225)
2010 (215)
2013 (196)
2012 (175)
2014 (161)
2011 (157)
2016 (91)
2008 (81)
2009 (72)
2022 (29)
2007 (29)
2024 (24)
2026 (23)
2023 (23)
2025 (18)
2020 (18)
2018 (17)
2005 (15)
2017 (15)
2004 (13)
2019 (10)
2006 (10)
2021 (7)
2002 (1)

UNIPROT ID/AC

F117A_HUMAN (12)
CELR3_HUMAN (12)
F193B_HUMAN (12)
Q05655 (6)
O14640 (6)
O15169 (6)
Q13905 (6)
P25054 (6)
P67775 (6)
Q15418 (6)
P01024 (6)
P30086 (6)
Q9UJU2 (6)
P35222 (6)
P62834 (6)
P49841 (6)
P27361 (6)
P15056 (6)
P01112 (6)
P01133 (6)
P00533 (6)
P47736 (6)
P60484 (6)
P31749 (6)
P04049 (6)
Q02750 (6)
P28482 (6)
P62070 (6)
Q07889 (6)
P20936 (6)

CHEBI ID

CHEBI:0016618 (6)
CHEBI:0018348 (6)
CHEBI:17568 (5)
CHEBI:6650 (4)
CHEBI:18050 (4)
CHEBI:15318 (4)
CHEBI:30915 (4)
CHEBI:16828 (4)
CHEBI:30769 (4)
CHEBI:32389 (3)
CHEBI:17521 (3)
CHEBI:18066 (3)
CHEBI:16113 (3)
CHEBI:4784 (3)
CHEBI:18132 (3)
CHEBI:16856 (3)
CHEBI:15978 (3)
CHEBI:17239 (3)
CHEBI:27570 (3)
CHEBI:15676 (3)
CHEBI:16708 (3)
CHEBI:17562 (3)
CHEBI:16750 (3)
CHEBI:16977 (3)
CHEBI:28875 (3)
CHEBI:15428 (3)
CHEBI:78697 (3)
CHEBI:6904 (3)
CHEBI:16196 (3)
CHEBI:16235 (3)

Metabolite Name

AMP (4)
UDP-glucose (3)
Histidine (3)
Glycine (3)
UMP (3)
L-Tryptophan (3)
L-Glutamate (3)
Xanthine (3)
L-Tyrosine (3)
Metconazole (2)
Pyraclostrobin (2)
Roxithromycin (2)
Cetirizine (2)
Fenofibrate (2)
Paroxetine (2)
Dodemorph (2)
Pioglitazone (2)
Quinate (2)
Glycerate (2)
Amoxicillin (2)
Cyclophosphamide (2)
Glutathione (2)
Flusilazole (2)
N1-Methyl-2-pyridone-5-carboxamide (2)
Uridine (2)
UDP (2)
Serine (2)
Proline (2)
Malate (2)
Lysine (2)

First Public Date

2022 (10)
2016 (8)
2024 (7)
2025 (6)
2026 (5)
2023 (5)
2014 (5)
2020 (4)
2018 (3)
2021 (2)
2019 (2)
2015 (1)

Modelling Approach

Ordinary differential equation model (7)

Study status

Recruiting (1)

Lab affiliation

Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. (5)
Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Nanjing Medical University, Nanjing, Jiangsu, China (3)
Centre for Cancer Cell & Molecular Biology Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ U.K. (2)
VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium (1)
Institute of Bioinformatics , International Technology Park, Bangalore, India (1)
Dept. of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (1)
Lineberger Comprehensive Cancer Center Department of Pharmacology UNC Chapel Hill Chapel Hill NC USA (1)
Division of Molecular Hematology, Department of Laboratory Medicine, Lund University (1)
Full Professor of Systems Biology and Director of Computational Modelling Systems Biology Ireland, University College Dublin, Dublin, Ireland. Conway Institute of Biomolecular & Biomedical Research,University College Dublin, Dublin, Ireland. School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA (1)
Head of Proteomics and Metabolomics Facility (1)
University Medicine Greifswald (1)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Lazarettgasse 14, AKH BT 25.3 A-1090 Vienna, Austria (1)
Winogradsky Institute of Microbiology, Research Center of Biotechnology, Russian Academy of Sciences, Moscow, Russia (1)
Division of Genome Sciences and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra (1)
Philips Institute for Oral Health Research, VCU School of Dentistry, Virginia Commonwealth University, Richmond, Virginia 23298, USA (1)
Laboratory of Biochemistry, Department of Medicine, University of Udine, Piazzale M. Kolbe 4, 33100 Udine, Italy (1)
National Key Laboratory of Medical Molecular Biology & Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (1)
Tsinghua University (1)
Hannover Medical School - Institute of Toxicology Research Core Unit - Proteomics Carl-Neuberg-Str. 1 30625 Hannover,Germany (1)

Keyword

Colorectal Cancer Stage IV, (1)
RAS gene mutation (1)
Microsatellite stable (1)
Capecitabine (1)
Bevacizumab (1)
Oxaliplatin (1)

IsPrivate

False (7)

Model Flag

Non Kinetic (1)

Classification

fungi (1)

Study type

Transcription profiling by array (980)
RNA-seq of coding RNA (171)
Unknown experiment type (57)
Comparative genomic hybridization by array (45)
ChIP-seq (42)
RNA-seq of non coding RNA (36)
Transcription profiling by tiling array (19)
ChIP-chip by tiling array (18)
Methylation profiling by array (17)
Other (14)
ChIP-chip by array (13)
Transcription profiling by RT-PCR (11)
Transcription profiling by SAGE (10)
Genotyping by array (10)
Proteomic profiling by array (10)
RNA-seq of coding RNA from single cells (6)
RNA-seq of total RNA (5)
Animal - High-throughput sequencing (4)
High-throughput sequencing (3)
RNAi profiling by array (3)
Human - One-color microarray (2)
DNA-seq (2)
Methylation profiling by high throughput sequencing (2)
ChIP-chip by SNP array (1)
Cell line - One-color microarray (1)
Cell line - High-throughput sequencing (1)
MicroRNA profiling by high throughput sequencing (1)
RIP-seq (1)
ScATAC-seq (1)
Single nucleus RNA sequencing (1)

Release Date

2015 (238)
2010 (222)
2013 (190)
2012 (184)
2014 (171)
2011 (166)
2016 (98)
2008 (84)
2009 (79)
2022 (72)
2023 (53)
2021 (53)
2025 (50)
2024 (48)
2020 (48)
2019 (41)
2018 (41)
2017 (34)
2007 (33)
2026 (18)
2005 (17)
2006 (16)
2004 (13)
1998 (2)
2002 (1)
2000 (1)
1999 (1)

Location

China (1)

Previous page
1 / 224
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 224
Next page

Sort by:

Relevance

Page size

Quantitative proteomics reveals that distant recurrence-associated protein R-Ras and Transgelin predict post-surgical survival of colorectal cancer Stage III patients

Surgical resection is the major clinical intervention for Stage III colorectal cancer (CRC) currently. However, as much as 30.8% of the patients who had ever taken curative resection came out of recurrence eventually. Therefore, to facilitate formulating effective treatment plans, there is an intens...

ORGANISM(S): Homo sapiens (Human)

2016-06-20 | PXD002903 | Pride